<!DOCTYPE html>

<html lang="fa">
<meta content="text/html;charset=utf-8" http-equiv="content-type"/>
<head><title>Limited efficacy of three times daily isordil dinitrate</title><link href="/d/css/bootstrap.min.css" rel="stylesheet"/><link href="/d/css/icofont.min.css" rel="stylesheet"/><link href="/d/css/classy-nav.min.css" rel="stylesheet"/><link href="/d/css/animate.css" rel="stylesheet"/><link href="/d/css/owl.carousel.css" rel="stylesheet"/><link href="/d/css/magnific-popup.css" rel="stylesheet"/><link href="/d/css/owl.theme.default.min.css" rel="stylesheet"/><link href="/d/css/style.css" rel="stylesheet"/><link href="/d/css/rtl_edited.css" rel="stylesheet"/><link href="/d/css/responsive.css" rel="stylesheet"/><link href="https://medilib.ir/uptodate_assets/main.css" rel="stylesheet">
<style>

#myUL {
  list-style-type: none;
  padding: 0;
  margin: 0;
}

#myUL li a {
  border: 1px solid #ddd;
  margin-top: -1px; /* Prevent double borders */
  background-color: #f6f6f6;
  padding: 12px;
  text-decoration: none;
  font-size: 16px;
  color: black;
  display: block
}

#myUL li a:hover:not(.header) {
  background-color: #eee;
}

#searchResult {

  list-style-type: none;
  padding: 0;
  padding-right: 20px;
}

#searchResult li a {
  border: .5px solid #ddd;
  margin-top: -1px; /* Prevent double borders */
  background-color: #79bc21;
  padding: 7px;
  text-decoration: none;
  font-size: 14px;
  color: white;
  display: block
}

#searchResult li a:hover:not(.header) {
  background-color: #222;
}


#txtHint   {
  position: absolute;
  text-shadow: none;
  width: 100%;
  margin-top: -15px;
  padding-right: 10px;

  filter: alpha(opacity=95);
  -moz-opacity: 0.95;
  opacity: 1;
  z-index: 200;
}
.countBubl {
  background:#eb0029;
  color:#fff;
  padding:5px;
  margin-top: 50%;

}
.uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > span:nth-child(1) > img:nth-child(2) {
 width: 55%;
 padding-left: 20px;
}
.uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > span:nth-child(1) > img:nth-child(3) {
 width: 20%;
}
 #Uptodate_image {
      width: 50%;
  }#uptodate-area {
      /*z-index: 99;*/
  }
#uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > div:nth-child(2) {
 margin-left: 10px;
 margin-bottom: 6%;
}
@media (max-width: @screen-xs) {
    .countBubl {
        font-size: 4px ;
    }
    #uptodate_version {
        font-size: 4px ;
    }
}

@media (max-width: @screen-sm) {
    .countBubl {
        font-size: 14px ;
    }
}
@media  all and(max-width: 820) {
    #Uptodate_image {
        width: 80% ;
    }#uptodate-area {
        z-index: 99;
    }
}@media  all and (min-width: 820) and(max-width: 88820){
    #Uptodate_image {
        width: 100% !important;
    }
    .countBubl {
        font-size: 4px ;
    }
}
div.col-md-3:nth-child(3) {
 margin-top: 6%;
}

div.col-md-3:nth-child(3) > img:nth-child(1) {
 width: 100%;
 margin-left: 11px;
}

</style>
<style media="screen" type="text/css">
  .goback {
    width: 200px;
    height: 40px;
    line-height: 40px;
    position: fixed;
    display: none;
    font-size: 15px;
    background: #71c0fa;
    z-index: 1000;
    text-align: center;
    color: #ffffff;
    -webkit-border-radius: 1px;
    -moz-border-radius: 1px;
    border-radius: 50px;
    bottom: 3.8%;
    right: 2%;
}
  .buyPackage {
  width: 100px;
  height: 100px;
  line-height: 40px;
  position: fixed;
  display: none;
  font-size: 10px;
  background: #fa759e;
  z-index: 1000;
  text-align: center;
  color: #ffffff;
  -webkit-border-radius: 1px;
  -moz-border-radius: 1px;
  border-radius: 10px;
  top: 150px;
  right: 2%;
  text-align: center;
}
.uptodate-area {
  /*background-image: url(../../assets/img/news-letter-bg.jpg);*/
  background-position: center center;
  background-size: cover;
  background-repeat: no-repeat;
    background-attachment: fixed;
  position: relative;
}
.uptodate-area::before {
  content: '';
  position: absolute;
  left: 0;
  padding-top: 100px;
  width: 100%;
}
#references{
  display: none;
}
</style>
<style>
section.sticky {
  position: sticky;
  top: 0;
  background-color: #fff !important;
  /*z-index: 100;*/
  /*padding-top: 80px;*/

}
.m4inb{
    border: solid !important;
  }

  .newsletter-area::before {
       background: unset !important;
  }
p {
    color: #555;
}
</style>

<meta content="" name="description"/>
<link href="/d/img/favicon.png" rel="icon" type="image/png"/>
</link></head>
<body>
<!-- Start Main Menu Area -->

<br/>
<br/>
<br/>
<br/>
<div class="container">
<div class="row">
</div>
</div>




<section class="teacher-area ptb-10">
<div class="container">
</div>

<section class="course-details-area ptb-60">
<div class="container">
<div class="uptodate2" style="padding:50px 0px 50px 0px;direction: ltr;text-align: left;">
<h1 style="text-align:center">Limited efficacy of three times daily isordil dinitrate</h1>
<div class="graphic"><div class="figure"><div class="ttl">Limited efficacy of three times daily isordil dinitrate</div><div class="cntnt"><img src="data:png;base64,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"/></div><div class="graphic_lgnd">Mean duration of exercise time to angina at different hours during days on which eight men with stable angina were given isosorbide dinitrate (ISDN) or placebo at 8 AM, 1 PM, and 6 PM (arrows). A signficant increase in exercise duration occurred after each dose of ISDN; however, the total duration of benefit was only about six hours.</div><div class="graphic_reference">Data from Bassan MM. J Am Coll Cardiol 1990; 16:936.</div><div id="graphicVersion">Graphic 79122 Version 2.0</div></div></div>
</div>
</div>

</section>

</section>
<!-- End Main Menu Area -->
<!-- Start Search Popup Area -->


<!-- End Footer Area -->
<!-- Back to top -->

<a class="scrolltop" href="#top"><i class="icofont-hand-drawn-up"></i></a>
<!-- End Back to top -->
<!-- jQuery Min JS -->

<!-- Prpper JS -->

<!-- Bootstrap Min JS -->

<!-- Classy Nav Min Js -->

<!-- Owl Carousel Min Js -->

<!-- Magnific Popup JS -->

<!-- CounterUp JS -->

<!-- Waypoints JS -->

<!-- Form Validator Min JS -->

<!-- Contact Form Min JS -->

<!-- Main JS -->

<!-- Global site tag (gtag.js) - Google Analytics -->






</body>
</html>
